Using Cellular Impedance Assays for the Discovery and Development of Novel Cancer Immunotherapies and Chemotherapies
Dr. Brandon Lamarche
Senior Scientist of Acea Biosciences, San Diego, USA
CD226 is a novel signalling domain for chimeric antigen receptors
Dr. Dang L. Vu
Senior Research Scientist for Tessa Therapeutics Pte Ltd
Date: Wednesday, 17 October, 2018
Time: 9:15am – 11:45am
Venue: MD3, Level 2, Lecture Theatre
Chairperson: Dr Deron Herr
You must be logged in to post a comment.